Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

THC Biomed Intl Ltd. (C:THC)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: Unit 1 - 2550 AclandRoad
KELOWNA BC V1X 7L4
Tel: N/A
Website: https://thcbiomed.com
IR: See website
Key People
John Miller
President, Chief Executive Officer, Director
Hee Jung Chun
Interim Chief Financial Officer
 
Business Overview
THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).
Financial Overview
For the nine months ended 30 April 2023, THC Biomed Intl Ltd revenues decreased 20% to C$2M. Net loss increased 37% to C$2.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Gain (loss) on sale of assets decrease from C$455K (income) to C$0K, Extinguishment of accounts payable decrease from C$170K (income) to C$0K.
Employees: 35 as of Jul 31, 2022
Reporting Currency: Canadian Dollars
Enterprise value: $7.28M as of Apr 30, 2023
Annual revenue (TTM): $2.86M as of Apr 30, 2023
EBITDA (TTM): -$2.19M as of Apr 30, 2023
Net annual income (TTM): -$3.67M as of Apr 30, 2023
Free cash flow (TTM): -$0.36M as of Apr 30, 2023
Net Debt Last Fiscal Year: $4.60M as of Apr 30, 2023
Shares outstanding: 168,938,556 as of Apr 30, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization